Helsinn Group Grants Exclusive Licensing Rights to Menarini fo...
LUGANO, Switzerland and FLORENCE, Italy, Dec. 22, 2018 /PRNewswire-AsiaNet/ -- Licensing rights are worldwide excluding US, Canada, Japan and South AmericaHelsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biopharmaceutical Group active in 136 countries worldwid...
Read more https://view-release/?pr-id=76884